Skip to content

Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial

Patient-centered and Efficacious Advance Care Planning in Cancer: the PEACe Comparative Effectiveness Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03824158
Enrollment
672
Registered
2019-01-31
Start date
2019-08-01
Completion date
2025-07-30
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advance Care Planning, Cancer

Keywords

cancer, advance care planning

Brief summary

The overall goal of this study is to identify the most effective and efficient advance care planning (ACP) strategy for patients with advanced cancer. The specific aims are to: Aim 1. Compare the effectiveness of in-person, facilitated ACP versus web-based ACP on patient and family caregiver outcomes. Aim 2. Assess implementation costs and the effects of in-person, facilitated ACP and web-based ACP on healthcare utilization at end of life. Aim 3. Identify contexts and mechanisms that influence the effectiveness of in-person, facilitated ACP versus web-based ACP.

Detailed description

Study investigators will conduct a single-blind, patient-level randomized trial to compare the effectiveness of two different patient-facing advance care planning (ACP) interventions. Investigators will enroll 400 patients with advanced cancer and their family caregivers to receive either (1) in-person discussions with trained facilitators or (2) web-based ACP using interactive videos. Because these approaches have never been compared directly, it is unclear whether one form of advance care planning is more potent, and if so, for whom and under what circumstances. Aim 1 compares the effectiveness of in-person, facilitated ACP versus web-based ACP on patient and family caregiver outcomes (ACP engagement, ACP discussions, advance directive completion, goal attainment, and caregiver psychological symptoms). Aim 2 assesses implementation costs of each intervention and effects on healthcare utilization at end of life. Aim 3 identifies contexts and mechanisms influencing the effectiveness of each approach. Primary patient outcomes will be assessed at 12 weeks. Participants will be followed until 12 weeks after the patient's death or completion of the 48-month data collection period, whichever occurs first. In-depth interviews with patients, caregivers, and clinicians will begin in Year 2 of the grant and continue until thematic saturation is reached.

Interventions

BEHAVIORALFacilitated advance care planning (in-person or telephonic)

The facilitator will contact the patient to schedule the ACP discussion. ACP discussions will be led by a nurse or social worker with supportive oncology experience who has been trained as a Respecting Choices facilitator, include the patient's caregiver when available, last 45-60 minutes, and be held in a private location at or near the patient's oncology clinic, or telephonically. Facilitators will use a structured interview tool as a discussion roadmap and provide guidance in choosing a medical decision maker, exploring serious illness understanding and experiences, identifying goals and values, and making future treatment decisions. Facilitators will provide a copy of a written advance directive, assist with completion when appropriate, and make recommendations for communicating goals and sharing written preferences.

BEHAVIORALWeb-based advance care planning

Instructions for accessing and using the PREPARE website will be shared with participants upon randomization. Patients and their caregivers review the 5 steps of PREPARE (approximately 10 minutes per step) and create an action plan for each step. The PREPARE website includes a link to a written advance directive that participants are able to complete. The PREPARE website can be reviewed on a home computer or on a tablet in the oncology practice.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
University of Pittsburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient Inclusion Criteria: 1. 18 years of age or older 2. Solid tumor 3. The oncologist would not be surprised if the patient died within the next year 4. Eastern Cooperative Oncology Group performance status (ECOG PS) of 0, 1, or 2 5. Planning to receive ongoing care at a participating oncology clinic 6. Willing to participate in either a web-based or facilitated program Patient

Exclusion criteria

1. Does not speak English 2. Inability to consent, using a validated teach-back method 3. Hematologic malignancy 4. No phone for additional study contacts and follow-up interviews 5. Unable to participate in advance care planning, as assessed by clinician 6. Unable to complete the baseline interview Patients will be able to identify and enroll a caregiver, designated by the patient as the primary family member or friend involved in their care and best able to participate in the study. Caregiver Inclusion criteria: 1. 18 years of age or older 2. Family member or friend of an eligible patient 3. Primary person involved in patient's care and best able to participate in the study, as assessed by patient Caregiver

Design outcomes

Primary

MeasureTime frameDescription
Advance Care Planning Engagement12 weeks15-item Advance Care Planning (ACP) engagement survey assesses ACP processes related to choosing a medical decision maker, discussing and documenting preference for care at end of life, flexibility for surrogate decision making, and asking questions of medical providers. A single summary score will be reported (range 0-5 with higher scores indicating higher engagement).

Secondary

MeasureTime frameDescription
Number of Participants Who Have Had Advance Care Planning Discussions With Physicians12 weeksHas \[participant\] talked with \[participant's\] doctor about the kind of medical care \[participant\] would want if \[participant\] were very sick or near the end of life?
Number of Participants Who Have Completed an Advance Directive12 weeksHas \[participant\] completed a living will or advance directive?
Documented Care Goals12 weeksInvestigators will assess documented care goals by reviewing medical records for any care goals documented since baseline (Yes/No).
Caregiver Depression Symptoms12 weeksDepression subscale of the 14-item Hospital Anxiety and Depression Scale (HADS) will be used to assess caregiver depression symptoms at 12 weeks and bereavement. The HADS depression subscale scores range from 0 to 21, with higher scores indicating more distress.
Caregiver Anxiety Symptoms12 weeksAnxiety subscale of the 14-item Hospital Anxiety and Depression Scale (HADS) will be used to assess caregiver anxiety symptoms at 12 weeks and bereavement. The anxiety subscale scores range from 0 to 21, with higher scores indicating more distress.
Receipt of Goal-concordant End-of-life Care - Patient Wishes Followedduring bereavement, up to 60 monthsBereaved caregivers will be asked In \[participant's\] opinion, to what extent were \[the patient's\] wishes followed in the medical care received in the last month of life? Receipt of goal-concordant end-of-life care - patient wishes followed will be defined as care that followed patients' wishes a great deal.
Receipt of Goal-concordant End-of-life Care - Place of Deathduring bereavement, up to 60 monthsBereaved caregivers will be asked about patient's preferred and actual places of death, with questions separated in the survey to minimize conscious comparison. Receipt of goal-concordant end-of-life care - place of death will be defined as patients dying in their preferred location.
Quality of End-of-life Careduring bereavement, up to 60 months13-item Caregiver Evaluation of Quality of End-of-Life Care (CEQUEL) scale. Total score range is 13-26, with higher scores indicating better perceived quality of care. Prolongation of Death, Perceived Suffering, and Preparation for the Death Subscales range 3-6, with higher scores indicating a better outcome. Shared Decision-Making subscale range is 4-8, with higher scores indicating a better outcome.
Caregiver Post-traumatic Stress Symptomsduring bereavement, up to 60 months22-item Impact of Events Scale-revised has a scoring range from 0-88, with a higher total score indicating more post-traumatic stress symptoms. Avoidance, Intrusions, and Hyperarousal Subscales range 0-4, with higher scores indicating a worse outcome.
Number of Participants Who Have Had Advance Care Planning Discussions With Caregivers12 weeksHas \[participant\] talked with \[participant's\] family or friends about the kind of medical care \[participant\] would want if \[participant\] were very sick or near the end of life?

Other

MeasureTime frameDescription
Number of Participants Admitted to Hospice Within Last 30 Days of LifeAssessed after patient deathInvestigators will measure whether the participant was admitted to hospice (Y/N)
Number of Participants Admitted to Hospice Within Last 3 Days of LifeAssessed after patient deathInvestigators will measure whether the participant was admitted to hospice for \< 3 days (Y/N)
Healthcare Utilization at End of Life - Hospice Length of StayAssessed after patient deathFor participants admitted to hospice, investigators will measure number of days in hospice.
Number of Participants Who Were Hospitalized Within Last 30 Days of LifeAssess after patient deathInvestigators will measure the number of participants hospitalized within in the last 30 days of life
Number of Participants Who Had Emergency Department Visits Within Last 30 Days of LifeAssessed after patient deathInvestigators will measure number of emergency department visits in the last 30 days of life
Advance Care Planning Implementation Coststhrough study completion, up to 5 yearsInvestigators will assess advance care planning implementation costs by tracking staff time spent on each intervention arm. Staff time costs for each intervention will be estimated by multiplying staff training and patient care time related to the intervention in hours by the average hourly wage for US nursing and social work staff of comparable levels.
Number of Participants Admitted to an Intensive Care Unit Within Last 30 Days of LifeAssessed after patient deathInvestigators will measure whether participant was admitted to the intensive care unit in the last 30 days of life (Y/N)
Number of Participants Who Received Chemotherapy Within Last 2 Weeks of LifeAssessed after patient deathInvestigators will measure whether chemotherapy was administered within the last 2 weeks of life (Y/N)

Countries

United States

Participant flow

Recruitment details

Recruitment occurred from August 1, 2019 until July 14, 2023. Patients were enrolled from 8 oncology clinics within the University of Pittsburgh Medical Center Hillman Cancer Center Network in western Pennsylvania. Patients were encouraged but not required to identify a caregiver, defined as the primary adult (family member or friend) involved in their care and best able to participate in the study, as assessed by the patient. Patients without a willing caregiver participant were not excluded.

Participants by arm

ArmCount
Web-based Advance Care Planning (PATIENTS)
Patients randomized to this arm will participate in web-based ACP via the PREPARE website. Web-based advance care planning: Instructions for accessing and using the PREPARE website will be shared with participants upon randomization. Patients and their caregivers review the 5 steps of PREPARE (approximately 10 minutes per step) and create an action plan for each step. The PREPARE website includes a link to a written advance directive that participants are able to complete. The PREPARE website can be reviewed on a home computer or on a tablet in the oncology practice.
203
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)
Patients randomized to this arm will participate in in-person or telephonic facilitated advance care planning (ACP) discussions using the Respecting Choices model. Facilitated advance care planning (in-person or telephonic): The facilitator will contact the patient to schedule the ACP discussion. ACP discussions will be led by a nurse or social worker with supportive oncology experience who has been trained as a Respecting Choices facilitator, include the patient's caregiver when available, last 45-60 minutes, and be held in a private location at or near the patient's oncology clinic, or telephonically. Facilitators will use a structured interview tool as a discussion roadmap and provide guidance in choosing a medical decision maker, exploring serious illness understanding and experiences, identifying goals and values, and making future treatment decisions. Facilitators will provide a copy of a written advance directive, assist with completion when appropriate, and make recommendations for communicating goals and sharing written preferences.
197
Web-based Advance Care Planning (CAREGIVERS)
Enrolled caregivers of patients randomized to the web-based advance care planning arm.
133
Facilitated Advance Care Planning (In-person or Telephonic) (CAREGIVERS)
Enrolled caregivers of patients randomized to the facilitated advance care planning arm.
139
Total672

Baseline characteristics

CharacteristicFacilitated Advance Care Planning (In-person or Telephonic) (CAREGIVERS)Web-based Advance Care Planning (CAREGIVERS)Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Web-based Advance Care Planning (PATIENTS)Total
Ability to manage on income
Cannot make ends meet
2 Participants8 Participants2 Participants6 Participants18 Participants
Ability to manage on income
Have enough with a little extra
54 Participants58 Participants77 Participants59 Participants248 Participants
Ability to manage on income
Just manage to get by
24 Participants21 Participants46 Participants51 Participants142 Participants
Ability to manage on income
Money is not a problem
41 Participants35 Participants48 Participants56 Participants180 Participants
Ability to manage on income
Refused to answer
18 Participants11 Participants24 Participants27 Participants80 Participants
Ability to manage on income
Unknown
0 Participants0 Participants0 Participants4 Participants4 Participants
Advance Care Planning (ACP) Engagement Survey Total Scores3.74 score on a scale
STANDARD_DEVIATION 1.02
3.66 score on a scale
STANDARD_DEVIATION 0.93
3.70 score on a scale
STANDARD_DEVIATION 0.98
Age, Continuous61.9 years
STANDARD_DEVIATION 13.5
62.2 years
STANDARD_DEVIATION 13.6
68.1 years
STANDARD_DEVIATION 11
67.8 years
STANDARD_DEVIATION 10
67.9 years
STANDARD_DEVIATION 10.5
Average days per week providing care5.59 days per week
STANDARD_DEVIATION 2.3
5.33 days per week
STANDARD_DEVIATION 2.3
5.46 days per week
STANDARD_DEVIATION 2.3
Average hours per day providing care7.15 hours per day
STANDARD_DEVIATION 7.9
6.92 hours per day
STANDARD_DEVIATION 8.1
7.03 hours per day
STANDARD_DEVIATION 8
Cancer type
Brain
0 Participants1 Participants1 Participants
Cancer type
Breast
31 Participants18 Participants49 Participants
Cancer type
Gastrointestinal
38 Participants39 Participants77 Participants
Cancer type
Genitourinary
20 Participants21 Participants41 Participants
Cancer type
Gynecologic
12 Participants7 Participants19 Participants
Cancer type
Head and Neck
10 Participants10 Participants20 Participants
Cancer type
Hepatobiliary
8 Participants9 Participants17 Participants
Cancer type
Lung
34 Participants48 Participants82 Participants
Cancer type
Melanoma
0 Participants1 Participants1 Participants
Cancer type
Other
4 Participants6 Participants10 Participants
Cancer type
Pancreatic
22 Participants20 Participants42 Participants
Cancer type
Prostate
18 Participants23 Participants41 Participants
Caregiver lives with the patient94 Participants98 Participants192 Participants
Confidence filling out medical forms
A little bit
3 Participants4 Participants9 Participants9 Participants25 Participants
Confidence filling out medical forms
Extremely
85 Participants81 Participants91 Participants94 Participants351 Participants
Confidence filling out medical forms
Not at all
3 Participants1 Participants7 Participants6 Participants17 Participants
Confidence filling out medical forms
Quite a bit
33 Participants31 Participants47 Participants40 Participants151 Participants
Confidence filling out medical forms
Somewhat
15 Participants16 Participants43 Participants54 Participants128 Participants
Current care provider for the patient124 Participants117 Participants241 Participants
Current employment status
Disability
6 Participants4 Participants22 Participants24 Participants56 Participants
Current employment status
Homemaker (never worked for pay)
3 Participants5 Participants4 Participants1 Participants13 Participants
Current employment status
Other
7 Participants10 Participants11 Participants16 Participants44 Participants
Current employment status
Refused to answer
1 Participants1 Participants3 Participants6 Participants11 Participants
Current employment status
Retired
62 Participants59 Participants120 Participants118 Participants359 Participants
Current employment status
Unemployed
2 Participants3 Participants9 Participants11 Participants25 Participants
Current employment status
Working full-time
46 Participants40 Participants21 Participants20 Participants127 Participants
Current employment status
Working part-time
12 Participants11 Participants7 Participants7 Participants37 Participants
Current living situation
In a Board and Care home
0 Participants0 Participants0 Participants
Current living situation
In a home I (or my family) own
155 Participants161 Participants316 Participants
Current living situation
In a home I (or my family) rent
28 Participants31 Participants59 Participants
Current living situation
In an Assisted Living Facility
3 Participants2 Participants5 Participants
Current living situation
In a Nursing Home
3 Participants0 Participants3 Participants
Current living situation
Other/Unsure
8 Participants6 Participants14 Participants
Current living situation
Refused to answer
0 Participants3 Participants3 Participants
Currently providing care for anyone else31 Participants29 Participants60 Participants
Current Marital Status
Divorced/Separated
10 Participants8 Participants28 Participants28 Participants74 Participants
Current Marital Status
Married
113 Participants105 Participants118 Participants125 Participants461 Participants
Current Marital Status
Never married
6 Participants12 Participants14 Participants16 Participants48 Participants
Current Marital Status
Refused to answer
1 Participants2 Participants0 Participants5 Participants8 Participants
Current Marital Status
Unknown
0 Participants0 Participants2 Participants1 Participants3 Participants
Current Marital Status
Widowed
9 Participants6 Participants35 Participants28 Participants78 Participants
ECOG Performance Status
ECOG Score - 0
68 Participants64 Participants132 Participants
ECOG Performance Status
ECOG Score - 1
102 Participants122 Participants224 Participants
ECOG Performance Status
ECOG Score - 2
27 Participants17 Participants44 Participants
Education Level
Graduate or professional degree
31 Participants24 Participants28 Participants25 Participants108 Participants
Education Level
< High school
3 Participants1 Participants6 Participants4 Participants14 Participants
Education Level
High school diploma or GED
36 Participants34 Participants63 Participants66 Participants199 Participants
Education Level
Refused to answer
0 Participants0 Participants1 Participants1 Participants2 Participants
Education Level
Some college or college degree
69 Participants74 Participants99 Participants107 Participants349 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants1 Participants3 Participants1 Participants6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
136 Participants132 Participants194 Participants201 Participants663 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants0 Participants0 Participants1 Participants3 Participants
HADS Survey Anxiety Subscale Scores7.44 score on a scale
STANDARD_DEVIATION 4.43
7.0 score on a scale
STANDARD_DEVIATION 4.1
5.15 score on a scale
STANDARD_DEVIATION 3.73
5.22 score on a scale
STANDARD_DEVIATION 3.69
5.19 score on a scale
STANDARD_DEVIATION 3.71
HADS Survey Depression Subscale Scores3.96 score on a scale
STANDARD_DEVIATION 3.43
4.22 score on a scale
STANDARD_DEVIATION 3.54
4.69 score on a scale
STANDARD_DEVIATION 3.52
4.62 score on a scale
STANDARD_DEVIATION 3.44
4.65 score on a scale
STANDARD_DEVIATION 3.48
How many other people live in your household?
0
10 Participants7 Participants49 Participants45 Participants111 Participants
How many other people live in your household?
1
95 Participants90 Participants110 Participants112 Participants407 Participants
How many other people live in your household?
2
17 Participants17 Participants24 Participants26 Participants84 Participants
How many other people live in your household?
3
14 Participants14 Participants12 Participants14 Participants54 Participants
How many other people live in your household?
4+
3 Participants5 Participants1 Participants4 Participants13 Participants
How many other people live in your household?
Unknown
0 Participants0 Participants1 Participants2 Participants3 Participants
Patient reported previously completing a living will or advance directive103 Participants95 Participants198 Participants
Patient reported previously having advance care planning discussions with caregivers136 Participants139 Participants275 Participants
Patient reported previously having advance care planning discussions with physicians53 Participants48 Participants101 Participants
Prior living will or advance directive in the medical record27 Participants24 Participants51 Participants
Prior POLST form in the medical record8 Participants4 Participants12 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants1 Participants0 Participants2 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants1 Participants1 Participants4 Participants
Race (NIH/OMB)
Black or African American
5 Participants6 Participants13 Participants17 Participants41 Participants
Race (NIH/OMB)
More than one race
0 Participants1 Participants1 Participants1 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
132 Participants125 Participants181 Participants184 Participants622 Participants
Region of Enrollment
United States
139 participants133 participants197 participants203 participants672 participants
Relationship to enrolled patient
Child
24 Participants25 Participants49 Participants
Relationship to enrolled patient
Friend
5 Participants2 Participants7 Participants
Relationship to enrolled patient
Other
9 Participants4 Participants13 Participants
Relationship to enrolled patient
Parent
4 Participants5 Participants9 Participants
Relationship to enrolled patient
Refused to answer
0 Participants1 Participants1 Participants
Relationship to enrolled patient
Sibling
12 Participants6 Participants18 Participants
Relationship to enrolled patient
Spouse/partner
85 Participants90 Participants175 Participants
Religion
Agnostic/Atheist/No religion
9 Participants5 Participants14 Participants8 Participants36 Participants
Religion
Buddhist
0 Participants0 Participants0 Participants1 Participants1 Participants
Religion
Catholic
56 Participants57 Participants72 Participants91 Participants276 Participants
Religion
Declined to answer
8 Participants9 Participants16 Participants18 Participants51 Participants
Religion
Hindu
1 Participants0 Participants1 Participants0 Participants2 Participants
Religion
Jewish
4 Participants3 Participants5 Participants3 Participants15 Participants
Religion
Muslim
0 Participants1 Participants0 Participants0 Participants1 Participants
Religion
Other
14 Participants13 Participants14 Participants15 Participants56 Participants
Religion
Other Christian
19 Participants12 Participants27 Participants24 Participants82 Participants
Religion
Protestant
28 Participants33 Participants48 Participants42 Participants151 Participants
Religion
Unknown
0 Participants0 Participants0 Participants1 Participants1 Participants
Religious importance
Fairly important
43 Participants39 Participants43 Participants53 Participants178 Participants
Religious importance
Not at all important
8 Participants2 Participants20 Participants9 Participants39 Participants
Religious importance
Not too important
21 Participants17 Participants25 Participants24 Participants87 Participants
Religious importance
Refused to answer
3 Participants7 Participants7 Participants10 Participants27 Participants
Religious importance
Unknown
0 Participants0 Participants1 Participants1 Participants2 Participants
Religious importance
Very important
64 Participants68 Participants101 Participants106 Participants339 Participants
Sex: Female, Male
Female
103 Participants96 Participants96 Participants96 Participants391 Participants
Sex: Female, Male
Male
36 Participants37 Participants101 Participants107 Participants281 Participants
Time receiving care from current oncologist
≥ 1 month but < 6 months
36 Participants40 Participants76 Participants
Time receiving care from current oncologist
≥ 1 year but < 2 years
29 Participants35 Participants64 Participants
Time receiving care from current oncologist
≥ 2 years but < 5 years
39 Participants41 Participants80 Participants
Time receiving care from current oncologist
≥ 5 years
31 Participants23 Participants54 Participants
Time receiving care from current oncologist
≥ 6 months but < 1 year
51 Participants48 Participants99 Participants
Time receiving care from current oncologist
Less than one month
11 Participants13 Participants24 Participants
Time receiving care from current oncologist
Refused to answer
0 Participants3 Participants3 Participants
Time since first diagnosed with cancer
≥ 1 month but < 6 months ago
31 Participants27 Participants58 Participants
Time since first diagnosed with cancer
≥ 1 year but < 2 years ago
23 Participants31 Participants54 Participants
Time since first diagnosed with cancer
≥ 2 years but < 5 years ago
39 Participants36 Participants75 Participants
Time since first diagnosed with cancer
≥ 5 years ago
53 Participants49 Participants102 Participants
Time since first diagnosed with cancer
≥ 6 months but < 1 year ago
43 Participants44 Participants87 Participants
Time since first diagnosed with cancer
Less than one month ago
6 Participants11 Participants17 Participants
Time since first diagnosed with cancer
Refused to answer
2 Participants4 Participants6 Participants
Time since first diagnosed with cancer
Unknown
0 Participants1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
112 / 203116 / 1970 / 1330 / 139
other
Total, other adverse events
0 / 2031 / 1970 / 1330 / 139
serious
Total, serious adverse events
0 / 2030 / 1970 / 1330 / 139

Outcome results

Primary

Advance Care Planning Engagement

15-item Advance Care Planning (ACP) engagement survey assesses ACP processes related to choosing a medical decision maker, discussing and documenting preference for care at end of life, flexibility for surrogate decision making, and asking questions of medical providers. A single summary score will be reported (range 0-5 with higher scores indicating higher engagement).

Time frame: 12 weeks

Population: Number of participants that completed 12 week outcomes assessment.

ArmMeasureValue (MEAN)Dispersion
Web-based Advance Care Planning (PATIENTS)Advance Care Planning Engagement4.08 score on a scaleStandard Deviation 0.82
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Advance Care Planning Engagement4.34 score on a scaleStandard Deviation 0.78
p-value: 0.0014Mixed Models Analysis
Secondary

Caregiver Anxiety Symptoms

Anxiety subscale of the 14-item Hospital Anxiety and Depression Scale (HADS) will be used to assess caregiver anxiety symptoms at 12 weeks and bereavement. The anxiety subscale scores range from 0 to 21, with higher scores indicating more distress.

Time frame: during bereavement, up to 60 months

Population: Bereaved caregivers

ArmMeasureValue (MEAN)Dispersion
Web-based Advance Care Planning (PATIENTS)Caregiver Anxiety Symptoms6.72 score on a scaleStandard Deviation 4.59
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Caregiver Anxiety Symptoms6.56 score on a scaleStandard Deviation 3.32
p-value: 0.84t-test, 2 sided
Secondary

Caregiver Anxiety Symptoms

Anxiety subscale of the 14-item Hospital Anxiety and Depression Scale (HADS) will be used to assess caregiver anxiety symptoms at 12 weeks and bereavement. The anxiety subscale scores range from 0 to 21, with higher scores indicating more distress.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Web-based Advance Care Planning (PATIENTS)Caregiver Anxiety Symptoms6.94 score on a scaleStandard Deviation 4.6
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Caregiver Anxiety Symptoms6.5 score on a scaleStandard Deviation 3.92
p-value: 0.11Mixed Models Analysis
Secondary

Caregiver Depression Symptoms

Depression subscale of the 14-item Hospital Anxiety and Depression Scale (HADS) will be used to assess caregiver depression symptoms at 12 weeks and bereavement. The HADS depression subscale scores range from 0 to 21, with higher scores indicating more distress.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Web-based Advance Care Planning (PATIENTS)Caregiver Depression Symptoms4.34 score on a scaleStandard Deviation 4.07
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Caregiver Depression Symptoms3.69 score on a scaleStandard Deviation 3.57
p-value: 0.17Mixed Models Analysis
Secondary

Caregiver Depression Symptoms

Depression subscale of the 14-item Hospital Anxiety and Depression Scale (HADS) will be used to assess caregiver depression symptoms at 12 weeks and bereavement. The HADS depression subscale scores range from 0 to 21, with higher scores indicating more distress.

Time frame: bereavement, up to 60 months

Population: Bereaved caregivers

ArmMeasureValue (MEAN)Dispersion
Web-based Advance Care Planning (PATIENTS)Caregiver Depression Symptoms5.87 score on a scaleStandard Deviation 4.11
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Caregiver Depression Symptoms5.34 score on a scaleStandard Deviation 6.56
p-value: 0.5t-test, 2 sided
Secondary

Caregiver Post-traumatic Stress Symptoms

22-item Impact of Events Scale-revised has a scoring range from 0-88, with a higher total score indicating more post-traumatic stress symptoms. Avoidance, Intrusions, and Hyperarousal Subscales range 0-4, with higher scores indicating a worse outcome.

Time frame: during bereavement, up to 60 months

Population: Bereaved caregivers

ArmMeasureGroupValue (MEAN)Dispersion
Web-based Advance Care Planning (PATIENTS)Caregiver Post-traumatic Stress SymptomsAvoidance subscale1.15 score on a scaleStandard Deviation 0.64
Web-based Advance Care Planning (PATIENTS)Caregiver Post-traumatic Stress SymptomsHyperarousal Subscale1.06 score on a scaleStandard Deviation 0.84
Web-based Advance Care Planning (PATIENTS)Caregiver Post-traumatic Stress SymptomsIntrusions Subscale1.99 score on a scaleStandard Deviation 0.89
Web-based Advance Care Planning (PATIENTS)Caregiver Post-traumatic Stress SymptomsIES-R Total Score31.5 score on a scaleStandard Deviation 15.2
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Caregiver Post-traumatic Stress SymptomsIntrusions Subscale1.48 score on a scaleStandard Deviation 0.86
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Caregiver Post-traumatic Stress SymptomsAvoidance subscale0.96 score on a scaleStandard Deviation 0.79
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Caregiver Post-traumatic Stress SymptomsIES-R Total Score23.9 score on a scaleStandard Deviation 14.6
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Caregiver Post-traumatic Stress SymptomsHyperarousal Subscale0.74 score on a scaleStandard Deviation 0.64
Comparison: IES-R Total Score p-valuep-value: 0.01t-test, 2 sided
Secondary

Documented Care Goals

Investigators will assess documented care goals by reviewing medical records for any care goals documented since baseline (Yes/No).

Time frame: 12 weeks

ArmMeasureGroupValue (NUMBER)
Web-based Advance Care Planning (PATIENTS)Documented Care GoalsNew advance directive or living will4 participants
Web-based Advance Care Planning (PATIENTS)Documented Care GoalsNew Physician Orders for Life-sustaining Treatment (POLST) form1 participants
Web-based Advance Care Planning (PATIENTS)Documented Care GoalsNew Code Status29 participants
Web-based Advance Care Planning (PATIENTS)Documented Care GoalsNew Goals of Care discussion26 participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Documented Care GoalsNew Goals of Care discussion22 participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Documented Care GoalsNew advance directive or living will18 participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Documented Care GoalsNew Code Status31 participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Documented Care GoalsNew Physician Orders for Life-sustaining Treatment (POLST) form8 participants
Comparison: Advance directive or living willp-value: 0.002Chi-squared
Comparison: POLSTp-value: 0.02Fisher Exact
Comparison: Code Statusp-value: 0.78Chi-squared
Comparison: Goals of Care discussionp-value: 0.61Chi-squared
Secondary

Number of Participants Who Have Completed an Advance Directive

Has \[participant\] completed a living will or advance directive?

Time frame: 12 weeks

Population: Number of participants that completed 12 week outcomes assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Number of Participants Who Have Completed an Advance Directive80 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Number of Participants Who Have Completed an Advance Directive101 Participants
p-value: 0.008Mixed Models Analysis
Secondary

Number of Participants Who Have Had Advance Care Planning Discussions With Caregivers

Has \[participant\] talked with \[participant's\] family or friends about the kind of medical care \[participant\] would want if \[participant\] were very sick or near the end of life?

Time frame: 12 weeks

Population: Number of participants that completed 12 week outcomes assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Number of Participants Who Have Had Advance Care Planning Discussions With Caregivers117 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Number of Participants Who Have Had Advance Care Planning Discussions With Caregivers120 Participants
p-value: 0.76Regression, Logistic
Secondary

Number of Participants Who Have Had Advance Care Planning Discussions With Physicians

Has \[participant\] talked with \[participant's\] doctor about the kind of medical care \[participant\] would want if \[participant\] were very sick or near the end of life?

Time frame: 12 weeks

Population: Number of participants that completed 12 week outcomes assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Number of Participants Who Have Had Advance Care Planning Discussions With Physicians54 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Number of Participants Who Have Had Advance Care Planning Discussions With Physicians67 Participants
p-value: 0.13Mixed Models Analysis
Secondary

Quality of End-of-life Care

13-item Caregiver Evaluation of Quality of End-of-Life Care (CEQUEL) scale. Total score range is 13-26, with higher scores indicating better perceived quality of care. Prolongation of Death, Perceived Suffering, and Preparation for the Death Subscales range 3-6, with higher scores indicating a better outcome. Shared Decision-Making subscale range is 4-8, with higher scores indicating a better outcome.

Time frame: during bereavement, up to 60 months

Population: Bereaved caregivers

ArmMeasureGroupValue (MEAN)Dispersion
Web-based Advance Care Planning (PATIENTS)Quality of End-of-life CarePerceived Suffering Subscale5.51 score on a scaleStandard Deviation 0.83
Web-based Advance Care Planning (PATIENTS)Quality of End-of-life CarePreparation for the Death subscale5.66 score on a scaleStandard Deviation 0.72
Web-based Advance Care Planning (PATIENTS)Quality of End-of-life CareShared Decision-Making subscale7.67 score on a scaleStandard Deviation 0.74
Web-based Advance Care Planning (PATIENTS)Quality of End-of-life CareTotal Score24.45 score on a scaleStandard Deviation 2.05
Web-based Advance Care Planning (PATIENTS)Quality of End-of-life CareProlongation of Death subscale5.62 score on a scaleStandard Deviation 0.78
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Quality of End-of-life CareTotal Score24.35 score on a scaleStandard Deviation 1.83
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Quality of End-of-life CareProlongation of Death subscale5.69 score on a scaleStandard Deviation 0.62
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Quality of End-of-life CarePerceived Suffering Subscale5.45 score on a scaleStandard Deviation 0.91
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Quality of End-of-life CareShared Decision-Making subscale7.7 score on a scaleStandard Deviation 0.68
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Quality of End-of-life CarePreparation for the Death subscale5.51 score on a scaleStandard Deviation 0.72
p-value: 0.32Wilcoxon (Mann-Whitney)
Secondary

Receipt of Goal-concordant End-of-life Care - Patient Wishes Followed

Bereaved caregivers will be asked In \[participant's\] opinion, to what extent were \[the patient's\] wishes followed in the medical care received in the last month of life? Receipt of goal-concordant end-of-life care - patient wishes followed will be defined as care that followed patients' wishes a great deal.

Time frame: during bereavement, up to 60 months

Population: Bereaved caregivers

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Receipt of Goal-concordant End-of-life Care - Patient Wishes FollowedA great deal37 Participants
Web-based Advance Care Planning (PATIENTS)Receipt of Goal-concordant End-of-life Care - Patient Wishes FollowedSomewhat11 Participants
Web-based Advance Care Planning (PATIENTS)Receipt of Goal-concordant End-of-life Care - Patient Wishes FollowedNot at all1 Participants
Web-based Advance Care Planning (PATIENTS)Receipt of Goal-concordant End-of-life Care - Patient Wishes FollowedDid not answer1 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Receipt of Goal-concordant End-of-life Care - Patient Wishes FollowedDid not answer0 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Receipt of Goal-concordant End-of-life Care - Patient Wishes FollowedA great deal46 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Receipt of Goal-concordant End-of-life Care - Patient Wishes FollowedNot at all0 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Receipt of Goal-concordant End-of-life Care - Patient Wishes FollowedSomewhat2 Participants
p-value: 0.01Fisher Exact
Secondary

Receipt of Goal-concordant End-of-life Care - Place of Death

Bereaved caregivers will be asked about patient's preferred and actual places of death, with questions separated in the survey to minimize conscious comparison. Receipt of goal-concordant end-of-life care - place of death will be defined as patients dying in their preferred location.

Time frame: during bereavement, up to 60 months

Population: Bereaved caregivers

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Receipt of Goal-concordant End-of-life Care - Place of Death34 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Receipt of Goal-concordant End-of-life Care - Place of Death37 Participants
p-value: 0.83Fisher Exact
Other Pre-specified

Advance Care Planning Implementation Costs

Investigators will assess advance care planning implementation costs by tracking staff time spent on each intervention arm. Staff time costs for each intervention will be estimated by multiplying staff training and patient care time related to the intervention in hours by the average hourly wage for US nursing and social work staff of comparable levels.

Time frame: through study completion, up to 5 years

Other Pre-specified

Healthcare Utilization at End of Life - Hospice Length of Stay

For participants admitted to hospice, investigators will measure number of days in hospice.

Time frame: Assessed after patient death

Population: Deceased patients

ArmMeasureValue (MEAN)Dispersion
Web-based Advance Care Planning (PATIENTS)Healthcare Utilization at End of Life - Hospice Length of Stay15.8 daysStandard Deviation 19.7
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Healthcare Utilization at End of Life - Hospice Length of Stay27.8 daysStandard Deviation 41.8
p-value: 0.09Wilcoxon (Mann-Whitney)
Other Pre-specified

Number of Participants Admitted to an Intensive Care Unit Within Last 30 Days of Life

Investigators will measure whether participant was admitted to the intensive care unit in the last 30 days of life (Y/N)

Time frame: Assessed after patient death

Population: Deceased patients

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Number of Participants Admitted to an Intensive Care Unit Within Last 30 Days of Life20 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Number of Participants Admitted to an Intensive Care Unit Within Last 30 Days of Life16 Participants
p-value: 0.4Chi-squared
Other Pre-specified

Number of Participants Admitted to Hospice Within Last 30 Days of Life

Investigators will measure whether the participant was admitted to hospice (Y/N)

Time frame: Assessed after patient death

Population: Deceased patients

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Number of Participants Admitted to Hospice Within Last 30 Days of Life64 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Number of Participants Admitted to Hospice Within Last 30 Days of Life76 Participants
p-value: 0.19Chi-squared
Other Pre-specified

Number of Participants Admitted to Hospice Within Last 3 Days of Life

Investigators will measure whether the participant was admitted to hospice for \< 3 days (Y/N)

Time frame: Assessed after patient death

Population: Deceased patients

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Number of Participants Admitted to Hospice Within Last 3 Days of Life19 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Number of Participants Admitted to Hospice Within Last 3 Days of Life25 Participants
p-value: 0.38Chi-squared
Other Pre-specified

Number of Participants Who Had Emergency Department Visits Within Last 30 Days of Life

Investigators will measure number of emergency department visits in the last 30 days of life

Time frame: Assessed after patient death

Population: Deceased patients

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Number of Participants Who Had Emergency Department Visits Within Last 30 Days of Life64 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Number of Participants Who Had Emergency Department Visits Within Last 30 Days of Life58 Participants
p-value: 0.28Chi-squared
Other Pre-specified

Number of Participants Who Received Chemotherapy Within Last 2 Weeks of Life

Investigators will measure whether chemotherapy was administered within the last 2 weeks of life (Y/N)

Time frame: Assessed after patient death

Population: Deceased patients

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Number of Participants Who Received Chemotherapy Within Last 2 Weeks of Life12 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Number of Participants Who Received Chemotherapy Within Last 2 Weeks of Life5 Participants
p-value: 0.07Chi-squared
Other Pre-specified

Number of Participants Who Were Hospitalized Within Last 30 Days of Life

Investigators will measure the number of participants hospitalized within in the last 30 days of life

Time frame: Assess after patient death

Population: Deceased patients

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Web-based Advance Care Planning (PATIENTS)Number of Participants Who Were Hospitalized Within Last 30 Days of Life74 Participants
Facilitated Advance Care Planning (In-person or Telephonic) (PATIENTS)Number of Participants Who Were Hospitalized Within Last 30 Days of Life67 Participants
p-value: 0.2Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026